Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Cerebrolysin for Sale > Cerebrolysin 60mg*6 vials
Cerebrolysin 60mg*6 vials buy - large image1
Cerebrolysin 60mg*6 vials buy - image1
Cerebrolysin 60mg*6 vials buy - image2
Cerebrolysin 60mg*6 vials buy - image3

Cerebrolysin 60mg*6 vials

COA 30 Inquiries

Unit Price:

$1/UNIT FOB

Get Latest Price
CAS No.:

12656-61-0

Grade:

Pharmaceutical Grade

Content:

99%

Port:

china

Packaging:

vials

Price valid (until):

2026-07-26

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    cerebrolysin  60mg  *6  vials one box, high quality and sold countless worldwide,  many good feedback.  if need others feel free to contact.

    Certificates

    Basic Info
    Product Name:

    Cerebrolysin

    Other Name:

    Cerebrolysin;FPE 1070

    CAS No.:

    12656-61-0

    EC Number:

    1592732-453-0

    Categories:

    Polypeptide

    Characteristics
  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2

    Location:

    Room 1-2208, Lianhecaifu Square, No2177, Tianchen Road, Gaoxin District, Jinan City, Shandong Province, China

    Payment Terms:

    L/C,100% TT in advance

    Average lead Time:

    3

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2012

    Certifications:

    business license

    Founded in 2012, Jinan Million Pharmaceutical Co., Ltd (Jinan Milin Pharmaceutical Co., Ltd) is a modern pharmaceutical enterprise guided by innovation. Million pharm has excellent research and development capabilities and complete industrial bases with international quality management system. It is dedicated to the research, development, production and customization of pharmaceuticals and advanced pharmaceutical intermediates.
     
    Jinan Million Pharmaceutical Co., Ltd has been focusing on the research of Cerebro-cardiovascular drugs, Central nervous system drugs, Anti-cancer drugs, Antibacterial drugs and others for 12 years; the products are: Apixaban, Lurasidone, Bexagliflozin, Votioxitine, Loxo-292/Selpercatinib, Baricitinib and intermediates. Million has worked with reputable customers, like METROCHEM API PVT LTD; BDR LIFESCIENCES PVT.LTD; INCETPAT PHARM; SRINI CHEM; EVA PHARMA; PHARMAFFILIATES ANALYTICS & SYNTHETICS (P) LTD; ....from India, Egypt, Canada...



    Jinan Million Pharmaceutical Co., Ltd has a 1,500㎡ R&D center in the Zhongguancun E Valley (Qihe) Incubator, equipped with complete test equipment, such as high-performance liquid chromatography, nuclear magnetic resonance spectrometer, liquid chromatography mass spectrometer, automatic polarimeter, etc., which can meet the needs of various  laboratory scale tests in different conditions. The pilot workshop is equipped with 50L and 100L glass reactors, high and low temperature equipment, etc., which can support organic chemical reactions at -100°C or 200°C. In addition, Million has a production site in Linyi city with many independent production lines, such as: production line of Apixabn intermediate 20 tons/year, production line of Lurasidon intermediate 10 tons/year, which can meet the commercial production of various products.
     
    The technical team is composed of high-level talents in major of pharmacy, bio-pharmaceutical or chemical synthesis, of which 10% has doctor’s degree and 15% has master’s degree. The team members are young and energetic with innovative spirit and willing to overcome obstacles.
     
    Jinan Million Pharmaceutical Co., Ltd adheres to the business philosophy of "dedication and innovation", insists on pioneering and innovating, constantly improves the quality system, and vigorously trains technical and management talents to build an elite team and serves customers better. Looking forward to cooperate with you for joint development and common progress.

  • Inquiry History
    30 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    High Quality cerebrolysin FPE 1070 Cerebrolysin powder 99% white powder 12656-61-0 Quanjinci

    28 KG Sep 26, 2023
    United States

    CEREBROLYSIN

    1 MT Mar 10, 2026
    United Kingdom

    Cerebrolysin (CBL60)

    10 MG Jun 18, 2026
    Brazil

    Cerebrolysin

    60 MG Apr 21, 2026
    United States

    Cerebrolysin

    1 KG Mar 23, 2026
    United States

    Cerebrolysin

    500 G Feb 9, 2026
    South Africa

    Cerebrolysin

    1 KG Dec 29, 2025
    United States

    cerebrolysn

    10 MG Dec 5, 2025
    United States

    Cerebrolysin

    50 G Jul 17, 2025
    Ireland

    Cerebrolysin

    Nov 4, 2024
    United States

    Cerebrolysin

    60 MG Jun 26, 2026
    United States

    cerebrolysin

    5 PCS May 26, 2026
    United States

    Cerebrolysin

    10 G Apr 7, 2026
    United States

    Cerebrolysin

    25 G Mar 23, 2026
    United States

    CEREBROLYSIN

    Feb 26, 2026
    United States

    Cerebrolysin

    60 MG Feb 26, 2026
    United States

    cerebrolysin

    1 KG Jan 20, 2026
    Lithuania

    High Quality Cerebrolysin

    1000 MG Jan 30, 2025
    Egypt

    Cerebrolysin

    1 G Dec 25, 2024
    South Korea

    cerebrolysin

    500 G Mar 28, 2024
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.